Is Addyi in shortage in 2026? Get the latest update on Addyi (Flibanserin) availability, pricing, and what patients can do to get their medication.
If you've tried to fill a prescription for Addyi (Flibanserin) recently and came up empty-handed, you might be wondering: is there an Addyi shortage?
The short answer is no — Addyi is not in a formal FDA-reported shortage. But that doesn't mean it's easy to find. Addyi has persistent availability challenges that make it feel like a shortage even when it technically isn't one. In this post, we'll break down what's really going on and what you can do about it.
Unlike medications that are affected by manufacturing disruptions or raw material shortages, Addyi's availability issues stem from its unique distribution model. Here's what's happening:
Addyi is primarily distributed through PhilRx, a mail-order pharmacy partnered with Sprout Pharmaceuticals. Most retail pharmacies — including major chains like CVS, Walgreens, and Walmart — don't stock Addyi because of low demand and the drug's distribution history.
Since its 2015 approval, Addyi has had lower-than-expected prescription volume. This means pharmacies have little incentive to keep it in stock. When a pharmacy doesn't regularly fill prescriptions for a medication, they simply don't order it from their wholesaler.
There is no generic Flibanserin available as of 2026. Generic entry is estimated for May 2028 at the earliest. Without generic versions, there's only one manufacturer and one primary distribution channel.
For the full backstory, read our post on why Addyi is so hard to find.
Cost is a major factor in Addyi accessibility. Here's the current pricing landscape:
Most Medicare plans and many commercial insurance plans do not cover Addyi. When coverage is available, prior authorization is typically required.
For detailed savings strategies, see our guide on how to save money on Addyi.
The HSDD treatment landscape remains limited but stable in 2026:
No new FDA-approved medications for HSDD have been introduced since Vyleesi in 2019. However, clinical research continues, and the expanded approval of Addyi for women under 65 (previously limited to premenopausal women) has broadened access somewhat.
Read more about your options in our guide to Addyi alternatives.
Here are the most effective strategies for getting your Addyi prescription filled in 2026:
Medfinder lets you check real-time pharmacy availability for Addyi near your location. It's the fastest way to find a local pharmacy that has it in stock without making dozens of phone calls.
PhilRx is the most reliable source for Addyi. They always have it in stock, offer competitive pricing ($149/month cash or as low as $20/month with insurance), and provide free home delivery. Visit addyicoupon.com to get started.
Independent pharmacies are often more willing to special-order medications that they don't normally stock. Call ahead and ask if they can order Addyi for you — many can get it within a few days.
Telehealth providers who specialize in women's sexual health are often familiar with Addyi's distribution process and can route your prescription directly to PhilRx. See our guide on finding a doctor who prescribes Addyi.
Addyi is not in a traditional drug shortage, but its limited distribution and high retail cost create real barriers for patients. The good news is that solutions exist: PhilRx mail-order provides reliable access at a fraction of the retail price, and tools like Medfinder can help you find local availability.
If you're a patient struggling to get your HSDD medication, don't assume Addyi is unavailable — it's more about knowing where to look. Check out our guide on how to find Addyi in stock near you for more detailed tips.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
